Here are three things to know.
1. The decision slashes 15 percent of the company’s workforce in West Virginia. About 3,000 people will remain employed.
2. A majority of the affected employees work in jobs related to operations.
3. Mylan said the layoffs were because the plant “needed to be rightsized and less complex,” after having a discussion with the FDA. Mylan did not specify the details on the discussion with the federal agency.
More articles on supply chain:
Amazon drops plan to become a major pharmaceutical distributor: 7 things to know
GSK divests line of rare disease drugs
FDA OKs 1st AI medical device that screens patients without physician interpretation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
